DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Loniten (Minoxidil) - Published Studies


Loniten Related Published Studies

Well-designed clinical trials related to Loniten (Minoxidil)

Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese men. [2009.08]

A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. [2007.11]

A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women. [2007.01]

K+ channel activation with minoxidil stimulates nasal-epithelial ion transport and blunts exaggerated hypoxic pulmonary hypertension. [2006.03]

Treatment of anal fissures using a combination of minoxidil and lignocaine: a randomized, double-blind trial. [2005.07]

Well-designed clinical trials possibly related to Loniten (Minoxidil)

Pharmacotherapy review of chronic pediatric hypertension. [2011.10]

Topical treatment and combination approaches for vitiligo: new insights, new developments. [2010.02]

Alopecia areata update: part II. Treatment. [2010]

Efficacy of combination therapy for the management regime of Alopecia areata. [2007.07]

Other research related to Loniten (Minoxidil)

Minoxidil 2% lotion for eyebrow enhancement: a randomized, double-blind, placebo-controlled, spilt-face comparative study. [2014]

Comparison of the efficacy of topical minoxidil 5% and adenosine 0.75% solutions on male androgenetic alopecia and measuring patient satisfaction rate. [2013]

Preparation and evaluation of a multimodal minoxidil microemulsion versus minoxidil alone in the treatment of androgenic alopecia of mixed etiology: a pilot study. [2013]

A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. [2011.12]

Transcutol containing vesicles for topical delivery of minoxidil. [2011.04]

Very large incidental pericardial effusion attributable to minoxidil: resolution without drainage. [2011.03]

Follicular and percutaneous penetration pathways of topically applied minoxidil foam. [2010.11]

In vitro skin permeation of monoolein nanoparticles containing hydroxypropyl beta-cyclodextrin/minoxidil complex. [2010.06.15]

Improvement in physicochemical parameters of DPPC liposomes and increase in skin permeation of aciclovir and minoxidil by the addition of cationic polymers. [2010.06]

Minoxidil-associated exudative pleural effusion. [2010.05]

Kerion Celsi favored by the use of a tretinoin+minoxidil+betamethasone valerate lotion in a 28-year-old woman. [2010.04]

Inhibition of isolated human myometrium contractility by minoxidil and reversal by glibenclamide. [2010.03]

Relative uptake of minoxidil into appendages and stratum corneum and permeation through human skin in vitro. [2010.02]

Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. [2009.10.01]

Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. [2009.07.30]

Fatal toxic epidermal necrolysis associated with minoxidil. [2009.04]

Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations. [2009.03]

Alopecia in congenital hidrotic ectodermal dysplasia responding to treatment with a combination of topical minoxidil and tretinoin. [2009.02]

After-rinsing hair growth promotion of minoxidil-containing amino alpha-cyclodextrins. [2007.12]

Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women. [2007.05]

Promotive effect of minoxidil combined with all-trans retinoic acid (tretinoin) on human hair growth in vitro. [2007.04]

Treatment of female pattern hair loss with a combination of spironolactone and minoxidil. [2007.02]

Liposomes and niosomes as potential carriers for dermal delivery of minoxidil. [2007.02]

The additive effects of minoxidil and retinol on human hair growth in vitro. [2007.01]

Stevens-Johnson syndrome associated with oral minoxidil: a case report. [2007.01]

Efficacy of 5% Minoxidil versus Combined 5% Minoxidil and 0.01% Tretinoin for Male Pattern Hair Loss : A Randomized, Double-Blind, Comparative Clinical Trial. [2007]

Is topical minoxidil solution effective on androgenetic alopecia in routine daily practice? [2007]

Effect of tocopheryl polyethylene glycol succinate on the percutaneous penetration of minoxidil from water/ethanol/polyethylene glycol 400 solutions. [2006.06]

Does the hyperfiltration of minoxidil result in increased proteinuria and loss of renoprotection conferred by angiotensin inhibition? [2006]

Simultaneous effects of tocopheryl polyethylene glycol succinate (TPGS) on local hair growth promotion and systemic absorption of topically applied minoxidil in a mouse model. [2005.12.08]

Influence of minoxidil on ischemic cutaneous flaps in rats. [2005.11]

Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution. [2005.07]

Other possibly related research studies

A model of orthostatic hypotension in the conscious monkey using lower body negative pressure. [2006.09]

Alopecia areata masquerading as frontal fibrosing alopecia. [2006.02]

Recent findings with computerized methods for scalp hair growth measurements. [2005.12]

Frontal fibrosing alopecia: a survey in 16 patients. [2005.11]

Psychological effect, pathophysiology, and management of androgenetic alopecia in men. [2005.10]

Alopecia areata: what to expect from current treatments. [2005.09]

Effective treatment of female androgenic alopecia with dutasteride. [2005.09]

Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. [2005.07.14]

Androgenetic alopecia and current methods of treatment. [2005.03]

Non surgical therapy for anal fissure. [2006.10.18]

Protection against chemotherapy-induced alopecia. [2006.11]

Efficacy of topical pimecrolimus in the treatment of chronic vulvar pruritus: a prospective case series--a non-controlled, open-label study. [2006]

Pathological circumstances impair the ability of "dark" neurons to undergo spontaneous recovery. [2006.09.19]

[Resistant hypertension and paradox effect in patient with hemodialysis treatment] [2006.03]

Usage of pain medications during stroke rehabilitation: the Post-Stroke Rehabilitation Outcomes Project (PSROP). [2005.09]

Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. [2005.12.15]

Treatment of hypertension in chronic kidney disease. [2005.11]

A proposal for a national program reporting beneficial drug responses, analogous to the existing program to detect adverse drug responses. [2006]

Treatment of female pattern hair loss with oral antiandrogens. [2005.03]

Congenital alopecia areata. [2005.02]

Evolution of techniques in hair transplantation: a 12-year perspective. [2007.02]

Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury. [2007.02.05]

Alopecia areata. [2007.02]

Androgenetic alopecia. [2007.06]

[Arterial hypertension in renal transplant recipients] [2007.04]

Female pattern hair loss: current treatment concepts. [2007]

Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies. [2008.01]

Improving care in resistant hypertension: medication trends and nonpharmacologic strategies in a specialty clinic. [2007]

Evaluation of blood flow parameters in addition to blood pressure and electrocardiogram in the conscious telemetered beagle dog. [2007.09]

Role of different types of potassium channels in the antidepressant-like effect of agmatine in the mouse forced swimming test. [2007.12.01]

Associations between sympathetic activity, plasma concentrations of renin, aldosterone, and parathyroid hormone, and the degree of intractability of blood pressure control in modialysis patients. [2007.08]

Interventions for alopecia areata. [2008.04.16]

Development and evaluation of polyherbal formulation for hair growth-promoting activity. [2007.06]

[Hair follicle regeneration] [2008.05]

Adolescent hair loss. [2008.08]

[Arterial hypertension - dosing recommendations at beginning and end of treatment] [2008.10]

Treatment of persistent alopecia areata with sulfasalazine. [2008.08]

Recent advances in the pharmacotherapy of chronic anal fissure: an update. [2008.07]

Hair transplantation for men. [2008.09]

Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models. [2008.08.28]

Hair growth promoting activity of Eclipta alba in male albino rats. [2008.08]

In vivo hair growth promotion effects of cosmetic preparations containing hinokitiol-loaded poly(epsilon-caprolacton) nanocapsules. [2008.08]

Diagnosing and treating hair loss. [2009.08.15]

Alopecia secondary to mesotherapy. [2009.10]

Potassium channels in health, disease & development of channel modulators. [2009.03]

The use of low-level light for hair growth: part I. [2009.06]

Androgens and hair loss. [2009.06]

Dermatologic medication in pregnancy. [2009]

Hair loss in women. [2009.03]

Alopecia areata: evidence-based treatments. [2009.03]

Chemotherapy-induced alopecia. [2009.03]

Activation of KATP channels increases anticancer drug delivery to brain tumors and survival. [2009.01.14]

Chemotherapy-induced hair loss. [2010.07]

Types of hair loss and treatment options, including the novel low-level light therapy and its proposed mechanism. [2010.09]

Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss. [2010.07]

Finasteride treatment of hair loss in women. [2010.06]

Male androgenetic alopecia. [2010.06]

Hair restoration in the ethnic patient and review of hair transplant fundamentals. [2010.02]

Hair growth in patients alopecia areata totalis after treatment with simvastatin and ezetimibe. [2010.01]

Alopecia areata update: part II. Treatment. [2010.02]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017